Home Transport stability profiling – a proposed generic protocol
Article
Licensed
Unlicensed Requires Authentication

Transport stability profiling – a proposed generic protocol

  • Lars Willems , Michael Paal ORCID logo and Michael Vogeser EMAIL logo
Published/Copyright: May 2, 2022

Abstract

Objectives

Diagnostic samples are exposed to a spectrum of variables during transport to laboratories; therefore, the evaluation of a rather comprehensive stability profile of measurands is warranted. While appropriate testing standards have been established for pharmaceuticals and reagents, this is not the case for diagnostic samples. The aim of our work was to develop and evaluate a protocol applicable to diagnostic samples.

Methods

An isochronous approach with representation of temperature and exposure duration in a two-dimensional matrix was established. The deviations of the measurement results from the baseline associated with the exposure are evaluated with respect to the measurement uncertainty of the analytical measurement procedure applied. Variables of the experiment are documented in a standardized matrix. As a proof-of-concept, we profiled the stability patterns of a number of measurands at four temperature levels over up to 72 h in primary serum sample tubes.

Results

The protocol proved to be workable and allowed the description of a comprehensive stability profile of a considerable number of compounds based on 21 small-volume primary samples collected from each volunteer and exposed according to this protocol.

Conclusions

A straightforward and feasible isochronous protocol can be used to investigate in detail the effects of different pre-processing conditions on the stability of measurands in primary samples during transport to diagnostic laboratories. This is of significance as pre-analytical logistics become increasingly important with the centralization of analytical services.


Corresponding author: Prof. Dr. med. Michael Vogeser, University Hospital, LMU Muenchen, Marchioninistr. 15, 81375 Munich, Germany, Phone: +49 89 4400 73221, E-mail:

Acknowledgments

We thank Prof. Klaus Parhofer, Department of Internal Medicine IV, and Dr. Florian Arend, Institute of Laboratory Medicine, University Hospital, LMU Munich, for reviewing the manuscript and their valuable input.

  1. Research funding: No funding.

  2. Author contribution: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The investigation was approved by the Institutional Review Board.

References

1. Sciacovelli, L, Panteghini, M, Lippi, G, Sumarac, Z, Cadamuro, J, Galoro, CAO, et al.. Defining a roadmap for harmonizing quality indicators in laboratory medicine: a consensus statement on behalf of the IFCC Working Group “Laboratory Error and Patient Safety” and EFLM Task and Finish Group “performance specifications for the extra-analytical phases”. Clin Chem Lab Med 2017;55:1478–88.https://doi.org/10.1515/cclm-2017-0412.Search in Google Scholar

2. Lippi, G, Guidi, GC, Mattiuzzi, C, Plebani, M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006;44:358–65.https://doi.org/10.1515/CCLM.2006.073.Search in Google Scholar

3. Patel, MK, El-Khoury, JM, Simundic, EA-M, Farnsworth, CW, Broell, F, Genzen, JR, et al.. Evolution of blood sample transportation and monitoring Technologies. Clin Chem 2021;67:812–9.https://doi.org/10.1093/clinchem/hvab001.Search in Google Scholar

4. Boyanton, BL, Blick, KE. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem 2002;48:2242–7.https://doi.org/10.1093/clinchem/48.12.2242.Search in Google Scholar

5. Jane Ellis, M, Livesey, JH, Evans, MJ. Hormone stability in human whole blood. Clin Biochem 2003;36:109–12.https://doi.org/10.1016/s0009-9120(02)00440-x.Search in Google Scholar

6. Young, DS. Effects of preanalytical variables on clinical laboratory tests, 3rd ed. Washington: AACC Press; 2007.Search in Google Scholar

7. Tanner, M, Kent, N, Smith, B, Fletcher, S, Lewer, M. Stability of common biochemical analytes in serum gel tubes subjected to various storage temperatures and times pre-centrifugation. Ann Clin Biochem 2008;45:375–9.https://doi.org/10.1258/acb.2007.007183.Search in Google Scholar PubMed

8. Zwart, SR, Wolf, M, Rogers, A, Rodgers, S, Gillman, PL, Hitchcox, K, et al.. Stability of analytes related to clinical chemistry and bone metabolism in blood specimens after delayed processing. Clin Biochem 2009;42:907–10.https://doi.org/10.1016/j.clinbiochem.2009.02.010.Search in Google Scholar PubMed

9. Oddoze, C, Lombard, E, Portugal, H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem 2012;45:464–9.https://doi.org/10.1016/j.clinbiochem.2012.01.012.Search in Google Scholar PubMed

10. Henriksen, LO, Faber, NR, Moller, MF, Nexo, E, Hansen, AB. Stability of 35 biochemical and immunological routine tests after 10 hours storage and transport of human whole blood at 21°C. Scand J Clin Lab Invest 2014;74:603–10.https://doi.org/10.3109/00365513.2014.928940.Search in Google Scholar PubMed PubMed Central

11. van Balveren, JA, Huijskens, MJ, Gemen, EF, Péquériaux, NC, Kusters, R. Effects of time and temperature on 48 routine chemistry, haematology and coagulation analytes in whole blood samples. Ann Clin Biochem 2017;54:448–62.https://doi.org/10.1177/0004563216665868.Search in Google Scholar PubMed

12. Wu, D-W, Li, Y-M, Wang, F. How long can we store blood samples: a systematic review and meta-analysis. EBioMedicine 2017;24:277–85.https://doi.org/10.1016/j.ebiom.2017.09.024.Search in Google Scholar PubMed PubMed Central

13. Gómez Rioja, R, Martínez Espartosa, D, Segovia, M, Ibarz, M, Llopis, MA, Bauça, JM, et al.. Laboratory sample stability. Is it possible to define a consensus stability function? An example of five blood magnitudes. Clin Chem Lab Med 2018;56:1806–18.10.1515/cclm-2017-1189Search in Google Scholar PubMed

14. Gao, J, Ulvik, A, McCann, A, Ueland, PM, Meyer, K. Microheterogeneity and preanalytical stability of protein biomarkers of inflammation and renal function. Talanta 2021;223:121774.https://doi.org/10.1016/j.talanta.2020.121774.Search in Google Scholar PubMed

15. Hedayati, M, Razavi, SA, Boroomand, S, Kheradmand Kia, S. The impact of pre-analytical variations on biochemical analytes stability: a systematic review. J Clin Lab Anal 2020;34:e23551.https://doi.org/10.1002/jcla.23551.Search in Google Scholar PubMed PubMed Central

16. Walter, M, Wiltfang, J, Vogelgsang, J. Pre-analytical sampling and storage conditions of amyloid-β peptides in venous and capillary blood. J Alzheimers Dis 2020;78:529–35.10.3233/JAD-200777Search in Google Scholar PubMed

17. Zaninotto, M, Tasinato, A, Padoan, A, Vecchiato, G, Pinato, A, Sciacovelli, L, et al.. An integrated system for monitoring the quality of sample transportation. Clin Biochem 2012;45:688–90.https://doi.org/10.1016/j.clinbiochem.2012.02.013.Search in Google Scholar PubMed

18. Zaninotto, M, Tasinato, A, Padoan, A, Vecchiato, G, Pinato, A, Sciacovelli, L, et al.. Effects of sample transportation on commonly requested laboratory tests. Clin Chem Lab Med 2012;50:1755–60.https://doi.org/10.1515/cclm-2012-0150.Search in Google Scholar PubMed

19. Cornes, M, Simundic, AM, Cadamuro, J, Costelloe, SJ, Baird, G, Kristensen, GBB, et al.. The CRESS checklist for reporting stability studies: on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the preanalytical phase (WG-PRE). Clin Chem Lab Med 2020;59:59–69.https://doi.org/10.1515/cclm-2020-0061.Search in Google Scholar PubMed

20. Pum, JKW. Evaluating sample stability in the clinical laboratory with the help of linear and non-linear regression analysis. Clin Chem Lab Med 2020;58:188–96.https://doi.org/10.1515/cclm-2019-0596.Search in Google Scholar PubMed

21. Panteghini, M, Ceriotti, F, Jones, G, Oosterhuis, W, Plebani, M, Sandberg, S, Task Force on Performance Specifications in Laboratory Medicine of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference. Clin Chem Lab Med 2017;55:1849–56.https://doi.org/10.1515/cclm-2017-0772.Search in Google Scholar PubMed

22. CLSI EP25A. Evaluation of stability of in vitro diagnostic reagents. Wayne, PA, USA: CLSI; 2009.Search in Google Scholar

23. ISO 23640:2015. In vitro diagnostic medical devices – evaluation of stability of in vitro diagnostic reagents. Geneva: International Standardization Organization; 2015.Search in Google Scholar

24. Gómez-Rioja, R, Segovia Amaro, M, Diaz-Garzón, J, Bauçà, JM, Martínez Espartosa, D, Fernández-Calle, P. Extra-Analytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML); Analytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML). A protocol for testing the stability of biochemical analytes. Technical document. Clin Chem Lab Med 2019;57:1829–36.10.1515/cclm-2019-0586Search in Google Scholar PubMed

25. World Health Organization Pharmaceuticals Unit. WHO guidelines on stability testing of pharmaceutical products containing well-established drug substances in conventional dosage forms. Geneva, CH: World Health Organization; 1994.Search in Google Scholar

26. U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Industry – Q1A(R2) Stability testing of new drug substances and products. Rockville, MD, USA: U.S. Department of Health and Human Services Food and Drug Administration; 2003.Search in Google Scholar

27. Lamberty, A, Schimmel, H, Pauwels, J. The study of the stability of reference materials by isochronous measurements. Fresenius’ J Anal Chem 1998;360:359–61.https://doi.org/10.1007/s002160050711.Search in Google Scholar

28. Linsinger, TP, Pauwels, J, Lamberty, A, Schimmel, HG, van der Veen, AM, Siekmann, L. Estimating the uncertainty of stability for matrix CRMs. Fresenius’ J Anal Chem 2001;370:183–8.https://doi.org/10.1007/s002160100719.Search in Google Scholar PubMed

29. Ammann, D, Becker, R, Nehls, I. Stability of ethyl glucuronide in hair reference materials after accelerated aging. Forensic Sci Int 2015;257:337–40.https://doi.org/10.1016/j.forsciint.2015.09.015.Search in Google Scholar PubMed

30. Ghini, V, Abuja, PM, Polasek, O, Kozera, L, Laiho, P, Anton, G, et al.. Metabolomic fingerprints in large population cohorts: impact of preanalytical heterogeneity. Clin Chem 2021;67:1153–5.https://doi.org/10.1093/clinchem/hvab092.Search in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2022-0032).


Received: 2022-01-11
Accepted: 2022-04-06
Published Online: 2022-05-02
Published in Print: 2022-06-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. The never-ending quest for antibody assays standardization and appropriate measurement units
  4. Review
  5. Glycated albumin in diabetes mellitus: a meta-analysis of diagnostic test accuracy
  6. Opinion Paper
  7. Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group
  8. Guidelines and Recommendations
  9. Recommendations for IVDR compliant in-house software development in clinical practice: a how-to paper with three use cases
  10. General Clinical Chemistry and Laboratory Medicine
  11. Comparison between polynomial regression and weighted least squares regression analysis for verification of analytical measurement range
  12. Transport stability profiling – a proposed generic protocol
  13. Impact of ultra-low temperature long-term storage on the preanalytical variability of twenty-one common biochemical analytes
  14. Development of a liquid chromatography mass spectrometry method for the determination of vitamin K1, menaquinone-4, menaquinone-7 and vitamin K1-2,3 epoxide in serum of individuals without vitamin K supplements
  15. TSH-receptor autoantibodies in patients with chronic thyroiditis and hypothyroidism
  16. Evaluation of the AFIAS-1 thyroid-stimulating hormone point of care test and comparison with laboratory-based devices
  17. Lack of analytical interference of dydrogesterone in progesterone immunoassays
  18. A comprehensive comparison between ISAC and ALEX2 multiplex test systems
  19. Detection of subarachnoid haemorrhage with spectrophotometry of cerebrospinal fluid – a comparison of two methods
  20. Importance of cerebrospinal fluid storage conditions for the Alzheimer’s disease diagnostics on an automated platform
  21. Estimating urine albumin to creatinine ratio from protein to creatinine ratio using same day measurement: validation of equations
  22. An automated, rapid fluorescent immunoassay to quantify serum soluble programmed death-1 (PD-1) protein using testing-on-a-probe biosensors
  23. Hematology and Coagulation
  24. The VES-Matic 5 system: performance of a novel instrument for measuring erythrocyte sedimentation rate
  25. Cancer Diagnostics
  26. Is thyroglobulin a reliable biomarker of differentiated thyroid cancer in patients treated by lobectomy? A systematic review and meta-analysis
  27. Cardiovascular Diseases
  28. The intra-individual variation of cardiac troponin I: the effects of sex, age, climatic season, and time between samples
  29. Infectious Diseases
  30. A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers
  31. Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens
  32. Cerebrospinal fluid markers of inflammation and brain injury in Lyme neuroborreliosis – a prospective follow-up study
  33. Letters to the Editors
  34. Misleading nomenclature of units of WHO materials used for standardization of SARS COv-2 serology
  35. Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster
  36. COVID-19 related mortality and religious denomination vs. genetics
  37. Unexpectedly low tacrolimus concentrations attributed to inappropriately labeled water container from the instrument manufacturer
  38. Effects of different pepsinogen cut offs in the screening of apparently healthy people
  39. Low levels of G17 and Barrett esophagus: a clinical relationship
  40. (In)direct chloride ISE measurements, room for improvement
  41. New concept of interactive academic poster used in medical scientific congress presented in the EuroMedLab 2021 Munich Session
Downloaded on 5.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2022-0032/html
Scroll to top button